RE: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Michel_Dumontier
> Many post-translational modifications like glycosylation > (http://www.functionalglycomics.org/static/index.shtml)in proteins > fundamentally change the (functional) 'nature' of the protein (as also the > molecular structure of the protein in case of glycosylation through > addition of sugar cha

RE: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Michel_Dumontier
> An interesting issue, one of identity. What determines the identity of > a molecule, a protein in this case? I strongly believe that the identity of a molecule is only dependent on its physical (chemical) composition. > If you have a protein that becomes > phosphorylated, is the phosphoryla

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Darren Natale
ke of Jackson Labs. PRO is being developed within the framework of the OBO Foundry, and aims to specify protein entities at the level mentioned by Chris (accounting for splice variation and post-translational modification and cleavage). Where appropriate, PRO will indeed make reference

RE: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread SATYA SANKET SAHOO
Original message >Date: Thu, 19 Jul 2007 16:29:18 -0400 >From: Michel_Dumontier <[EMAIL PROTECTED]> >Subject: RE: protein entities (was Re: Rules (was Re: Ambiguous names. was: >Re: URL +1, LSID -1) >To: Darren Natale <[EMAIL PROTECTED]>, Michel_Dumont

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread June Kinoshita
tium), Barry Smith of SUNY Buffalo, and Judy Blake of Jackson Labs. PRO is being developed within the framework of the OBO Foundry, and aims to specify protein entities at the level mentioned by Chris (accounting for splice variation and post-translational modification and cleavage). Wher

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Waclaw Kusnierczyk
Michel_Dumontier wrote: Darren, Also, while we recognize that there are different qualities that can be ascribed to a basically identical biochemical entity in different structural conformations or states of ligand binding, we are not attempting (at least in the beginning) to describe these st

RE: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Michel_Dumontier
Darren, > Also, while we recognize > that there are different qualities that can be ascribed to a basically > identical biochemical entity in different structural conformations or > states of ligand binding, we are not attempting (at least in the > beginning) to describe these structural conforma

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Waclaw Kusnierczyk
Michel_Dumontier wrote: Sequence form is again a placeholder term ... ... distinguish between a phosphorylated version of a protein and the non-phosphorylated version (as an example). The need for the latter derives from the fact that the two versions might have different functions. Inde

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Darren Natale
Original Message- From: [EMAIL PROTECTED] [mailto:public-semweb-lifesci- [EMAIL PROTECTED] On Behalf Of Darren Natale Sent: Thursday, July 19, 2007 11:24 AM To: Eric Jain Cc: Alan Ruttenberg; Chris Mungall; Bijan Parsia; public-semweb-lifesci hcls Subject: Re: protein entities (w

RE: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Michel_Dumontier
9, 2007 11:24 AM > To: Eric Jain > Cc: Alan Ruttenberg; Chris Mungall; Bijan Parsia; public-semweb-lifesci > hcls > Subject: Re: protein entities (was Re: Rules (was Re: Ambiguous names. > was: Re: URL +1, LSID -1) > > > We don't yet have formal definitions for many of t

Re: protein entities

2007-07-19 Thread Waclaw Kusnierczyk
Darren Natale wrote: Protein, in this scheme, is the amino acid polymer produced by a translation process using an mRNA as a template. This fits about any polypeptide produced by a ribosome. I'd think that the term 'protein' is reserved for some, but not all polypeptides (even if we talk

protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Darren Natale
ing the PIs Cathy Wu of PIR (which is also a member organization of the UniProt Consortium), Barry Smith of SUNY Buffalo, and Judy Blake of Jackson Labs. PRO is being developed within the framework of the OBO Foundry, and aims to specify protein entities at the level mentioned by Chris (ac

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Darren Natale
the UniProt Consortium), Barry Smith of SUNY Buffalo, and Judy Blake of Jackson Labs. PRO is being developed within the framework of the OBO Foundry, and aims to specify protein entities at the level mentioned by Chris (accounting for splice variation and post-translational modification and

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Darren Natale
Protein, in this scheme, is the amino acid polymer produced by a translation process using an mRNA as a template. I suppose this excludes peptides (also amino acid polymers) that are produced non-ribosomally, but perhaps that is okay for the time being. The precise definition will be constr

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Eric Jain
Darren Natale wrote: We don't yet have formal definitions for many of the classes and relations (the effort only began in earnest a few months ago). But, basically, there is a distinction made between the full-length (in terms of amino acid sequence) protein and the sub-length parts of protei

Re: protein entities (was Re: Rules (was Re: Ambiguous names. was: Re: URL +1, LSID -1)

2007-07-19 Thread Eric Jain
ation of the UniProt Consortium), Barry Smith of SUNY Buffalo, and Judy Blake of Jackson Labs. PRO is being developed within the framework of the OBO Foundry, and aims to specify protein entities at the level mentioned by Chris (accounting for splice variation and post-translational modification a